Drug intelligence / Profile preview

carbamazepine + diazepam

Development stage
Unknown
Lead developer
Novartis
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular, Rectal, Intranasal
01

Overview

Carbamazepine + diazepam is a combination of two pharmaceutical drugs, each with distinct mechanisms of action. Carbamazepine is an anticonvulsant and mood-stabilizing agent primarily used to treat various types of seizures, trigeminal neuralgia (a type of nerve pain), and bipolar disorder. It works mainly by inhibiting voltage-gated sodium channels in neuronal membranes, stabilizing hyperexcited nerve cells and reducing synaptic transmission. Diazepam is a long-acting benzodiazepine used for its anxiolytic, muscle relaxant, anticonvulsant, and sedative properties. It acts as a positive allosteric modulator at the gamma-aminobutyric acid type A (GABA-A) receptor complex in the central nervous system, enhancing GABAergic inhibition[4][5][6][8]. The combination may be considered in clinical scenarios where both seizure control and acute anxiety or muscle spasm management are required; however, co-administration can result in pharmacokinetic interactions that may reduce the effectiveness of diazepam due to enzyme induction by carbamazepine[1][2].

02

Targets

NaV (Voltage-gated sodium channels)GABRR (GABA-A receptor subunit rho)

Beyond the preview

Go deeper on carbamazepine + diazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carbamazepine + diazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call